Safran and AFM-Téléthon team up for 2012 Vendée Globe round-the-world race

Paris, September 4, 2012

Since 2005 Safran has sponsored a major ocean racing team alongside skipper Marc Guillemot, reflecting its corporate values of innovation and solidarity. With the next Vendée Globe round-the-world race scheduled for the end of the year, Safran is reaffirming its support for AFM-Téléthon, the French Muscular Dystrophy Association (AFM), in its fight against rare genetic diseases.

This partnership was initiated by Safran as part of its corporate philanthropy approach, to promote the association's actions and provide financial support for research and development of innovative therapies for rare illnesses.

Several actions are being implemented in the run-up to the Vendée Globe round-the-world solo race, scheduled to start on November 10:

- Marc Guillemot met two children with rare genetic diseases, Gwenaël and Myriem, on August 31 at La Trinité-sur-Mer in Brittany. During the race, they will stay in contact with the skipper thanks to regularly scheduled conference calls via radio.
- On October 16, the Orchestre de l'Alliance will give a benefit concert for AFM-Téléthon at the Salle Gaveau in Paris, thanks to active support from Safran, with both Marc Guillemot and the children in attendance.
- A video retracing the partnership between Safran and AFM-Téléthon will be viewable on the site www.safran-sailingteam.com starting November 10. With each click on the video link, a euro will be donated to the association.

Marc Guillemot also met Philippe Moullier, Scientific Director of the Nantes Gene Therapy Center, one of the leading laboratories for gene therapy in France, which has enjoyed long-standing support from AFM-Téléthon. "What's similar in Safran's boat sponsorship and the AFM-Téléthon's actions is not only the teamwork involved, but also the continuous quest for innovation," said Marc Guillemot. "Over and above its role as a sponsor, Safran is very actively involved in the design, construction and development of its ocean racer. More than 100 Safran engineers from a number of different disciplines have contributed their expertise in composite materials, computer modeling, hydraulics, strength computations and tests, onboard electronics and other areas – a first in the history of sponsoring racing boat. The innovative approach taken by AFM-Téléthon and Philippe Moullier to cure children with rare diseases is very similar, and touches me deeply. This year, Safran will be sailing more than ever for a worthy cause!"

Philippe Moullier added: "I'm a keen sailing enthusiast myself, and this year, even more than the others, I'll be following Marc and Safran in the Vendée Globe. In research, we do a lot of sailing 'close to the wind', and rarely downwind. It's difficult to know what's going to happen tomorrow, even if we know exactly the route we've already taken."

To support the Safran-AFM-Téléthon partnership and get the latest news, go to http://www.safran-sailingteam.com/

To purchase tickets for the October 16 concert (12 to 50 euros):
Salle Gaveau - 45 rue la Boétie - 75008 Paris - www.sallegaveau.com - 01 49 53 05 07
Online: www.fnac.com - 0 892 68 36 22 (0,34€/min), www.carrefourspectacles.com, www.francebillet.com

***

Safran is a leading international high-technology group with three core businesses: Aerospace (propulsion and equipment), Defence and Security. Operating worldwide, the Safran group has close to 60,000 employees and generated sales of 11.7 billion euros in 2011. Working alone or in partnership, Safran holds world or European leadership positions in its core markets. The Group invests heavily in Research & Development to meet the requirements of changing markets, including expenditures of 1.3 billion euros in 2011. Safran is listed on NYSE Euronext Paris and is part of the CAC40 index.

For more information, www.safran-group.com - Follow @SAFRAN on Twitter

AFM-Téléthon is the French Muscular Dystrophy Association for patients and their families. Created in 1958, it has always focused on a single objective: to fight against and cure rare genetic diseases that have long been widely ignored. Thanks to the extraordinary popular support generated by the Telethon for the last 25 years, and driven by a single-minded focus on helping patients, this association has become a major player in research and the development of innovative therapies for rare diseases, thus contributing to the emergence of a real medical revolution that will benefit the largest number of people. AFM-Téléthon currently supports 36 clinical tests concerning about 30 diseases (rare skin, muscular, eye, blood and liver diseases, heart attacks, etc). At the end of 2011, AFM-Téléthon united four leading gene and cellular therapy laboratories (Généthon, Institut de myologie, I-Stem, Pôle nantais de thérapie génique) in a Biotherapy Institute with 650 experts in medical research and development, forming an unrivaled strike force to overcome disease!

For further information, see www.afm-telethon.fr

Follow @AfmPresse on Twitter

Groupe Safran
Direction de la Communication
2, bd du Général Martial Valin
75724 Paris Cedex 15 – France
www.safran-group.com

Press Contact:
Caroline COUDERT
Tél +33 (0)1 40 60 82 20
Fax +33 (0)1 40 60 80 26
caroline.coudert@safran.fr

AFM-Téléthon
Press Contact:
Stéphanie BARDON
Tél : 01 69 47 12 78
sbardon@afm.genethon.fr